Form 4: Mind Medicine (MindMed) Executive Receives Stock Grant
Insider Transaction (Form 4)
Matthew T. Wiley, Chief Commercial Officer of Mind Medicine (MindMed) Inc., received 125,000 shares of common stock on September 14, 2026.
Summary
- Grant/award: acquired 125,000 Common Shares on September 14, 2026; holds 362,133 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Matthew T. Wiley — Officer (Chief Commercial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-14 | Grant/award | Common Shares | 125,000 | — | — | 362,133 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-14 | Grant/award (125,000 shares) |
Keywords
insider transaction, Form 4, DFTX, Definium Therapeutics, Inc., neutral, Matthew T. Wiley
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.